Neurocrine Biosciences Reports Strong Q3 Results, RBC Says
RBC described Neurocrine Biosciences' Q3 results as strong.
Related stories
CMS Energy Issues $1 Billion of 6.800% Notes Due 2057
CMS Energy issued $1 billion of 6.800% fixed-to-fixed reset rate junior subordinated notes due 2057.
M impact | EQUITY | Nov 03, 2026, 05:33 PM UTC
Balu Forge Begins 155mm Shell Dispatches and Secures New Orders
Balu Forge Industries says it has begun dispatching 152mm empty artillery shells and secured quality approval for 155mm extended-range full-bore shells. It also reports new orders
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
Bata India Q2 Profit Rises 28.6% as EBITDA Margin Falls to 16.7%
Bata India reported consolidated Q2FY27 revenue of Rs 862 crore and net profit of Rs 18 crore, up from Rs 14 crore a year earlier. EBITDA margin fell to 16.7%.
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
V-Mart Retail Q2 Loss Widens to Rs 16 Crore as Revenue Rises 18%
The retailer's EBITDA increased year on year to Rs 86.1 crore, with its margin improving marginally.
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
Leap Partners Acquires 360 Plumbing Service in Richmond
Leap Partners acquired 360 Plumbing Service in the Richmond area, expanding its presence into Virginia.
M impact | EQUITY | Nov 03, 2026, 05:32 PM UTC
Magellan Copper & Gold Reports Third-Quarter Net Loss of $23.4K
The company reported a net loss of $23.4K for the third quarter of 2026, compared with a $153.3K loss a year earlier. Diluted loss per share was $(0.00), versus $(0.01).
M impact | EQUITY | Nov 03, 2026, 05:31 PM UTC